Skip to content

Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01908920
Enrollment
60
Registered
2013-07-26
Start date
2013-05-31
Completion date
2013-09-30
Last updated
2013-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subject, Heart Rate Variability

Brief summary

The aim of the present study is to determine the extend to which osteopathic manipulative treatment (OMT) is effective on a sample of healthy subjects in changing high frequency (HF) parameters.

Interventions

OTHEROsteopathic manipulative treatment
OTHERSHAM
OTHERCONTROL

Sponsors

European Institute for Evidence Based Osteopathic Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 45; * No chronic symptomatology; * No acute symptomatology during the last 72 hours before intervention; * No pathologies

Exclusion criteria

* Age below 18 or over 45; * Pregnancy; * Menopause; * Abuse of alcool during the last 48 hours; * Chronic pain; * Acute pain during the last 72 hours; * Conclamate pathologies; * Use of drugs during the last 72 hours ; * Use of ortothic devices during the last 3 months; * Any type of surgery; * Osteopathic treatment during the last 3 months.

Design outcomes

Primary

MeasureTime frame
Change from baseline high frequency (HF) value at 1 weekbaseline and 1 week

Secondary

MeasureTime frame
Change in VLF valueduring treatment session
Change in SDNN valueduring treatment session
Change in RMSSD valueduring treatment session
Change in pNN50 valueduring treatment session
Change in DFAa1 valueduring treatment session
Change from baseline intrasubject HF value at 1 weekbaseline and 1 week
Change from baseline standard deviation beat-to-beat (SDNN) value at 1 weekbaseline and 1 week
Changes from baseline square root of the mean squared difference of successive beat-to-beat (RMSSD) at 1 weekbaseline and 1 week
Change in LF/HF ratio valueduring treatment session
Change in LF valueduring treatment session
Change from baseline proportion of beat-to-beat50 divided by total number of beat-to-beats in (pNN50) at 1 weekbaseline and 1 week
Change from baseline in low frequency (LF) value at 1 weekbaseline and 1 week
Change from baseline LF/HF ratio value at 1 weekbaseline and 1 week
Change from baseline very low frequency (VLF) value at 1 weekbaseline and 1 week
Change from baseline heart rate variability parameters between smokers and no-smokers at 1 weekbaseline and 1 week
Change from baseline 15D questionnaire at 1 weekbaseline and 1 week
Differences in skin conductance value between groups1 week
Change from baseline detrended fluctuation scaling exponent (DFAa1) value at 1 weekbaseline and 1 week

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026